Related Experiment Video
Updated: May 15, 2026

14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Identification of methicillin-resistant Staphylococcus aureus using an integrated and modular microfluidic system
Yi-Wen Chen1, Hong Wang, Mateusz Hupert
1Department of Chemistry, Louisiana State University, Baton Rouge, LA 70803, USA.
The Analyst
|January 12, 2013
Summary
This study introduces a microfluidic system for rapid Methicillin-resistant Staphylococcus aureus (MRSA) detection. The integrated device identifies MRSA strains in under 40 minutes, differentiating hospital-acquired from community-acquired infections.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Molecular Diagnostics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, necessitating rapid and accurate detection methods.
- Current diagnostic approaches can be time-consuming, delaying appropriate patient treatment and infection control.
Purpose of the Study:
- To develop an integrated, modular microfluidic system for the rapid and specific identification of MRSA.
- To enable simultaneous detection of key genes for differentiating MRSA strains and species.
Main Methods:
- A modular microfluidic cartridge was designed, integrating PCR amplification and ligase detection reaction (LDR) on a universal DNA array.
- The system utilized a thermoplastic module for the array and a polycarbonate motherboard for PCR/LDR, with off-chip fluid handling and optical readout.
- Multiplexed PCR/LDR detected five genes: SG16S, spa, femA, PVL, and mecA.
Main Results:
- The system successfully identified MRSA strains in under 40 minutes.
- It differentiated community-acquired MRSA (CA-MRSA) from hospital-acquired MRSA (HA-MRSA) based on the presence of the PVL gene.
- The system could distinguish Staphylococcus aureus from other Staphylococcal species using the femA gene sequence.
Conclusions:
- The developed modular microfluidic system offers a rapid, efficient, and specific platform for MRSA identification.
- This technology has the potential to significantly improve early diagnosis, treatment, and infection control of MRSA.
- The system's ability to differentiate MRSA subtypes and species from mixed samples enhances its clinical utility.
